Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle

Owa, Takashi, Yoshino, Hiroshi, Okauchi, Tatsuo, Yoshimatsu, Kentaro, Ozawa, Yoichi, Sugi, Naoko Hata, Nagasu, Takeshi, Koyanagi, Nozomu +1 more·1999·Journal of Medicinal Chemistry

Cited by (342)

Items 301–342 of 342

  1. Expression of Carbonic Anhydrases IX and XII in Embryonic and Adult Mouse Tissues
    Heini M. L. Kallio · 2006 · Tampere University Institutional Repository (Tampere University)
  2. 低分子リガンドによる選択的タンパク質分解誘導作用
    Taisuke Uehara, Takashi Owa · 2017 · KAGAKU TO SEIBUTSU
  3. Compounds for the treatment of oestrogen-dependent illnesses
    2000 · Expert Opinion on Therapeutic Patents
  4. Modern Trends in the Copper-Catalyzed Synthesis of Sulfonamides
    Prakash Chandra, Neha Choudhary, Goutam Kumar Lahiri, Debabrata Maiti, Mobin M. Shaikh · 2022 · Research Square
  5. Destruction with a Purpose: Targeted Protein Degradation in Drug Discovery
    Paola Martinelli, Christiane C. Kofink, Georg Boeck, Harald Weinstabl, Manfred Koegl · 2022 · Wiley eBooks
  6. Research progress in small-molecule modulators of protein-protein interactions
    Bin Yang, Xiangbing Qi · 2023 · Chinese Science Bulletin (Chinese Version)
  7. Indisulam Treatment Degrades Rbm39 and Inhibits Acute Megakaryoblastic Leukemia by Affecting Alternative Splicing of Zmynd8
    Ying Hua Yang, Zhiheng Li, Yang Yang, Peifang Xiao, Zhixu He, Zimu Zhang, Yizhen Li, Lei Shi, Xiaodong Wang, Yanfang Tao et al. · 2024 · SSRN Electronic Journal
  8. Pre‐mRNA Splicing Modulation
    Scott J. Barraza, Matthew G. Woll · 2024 · Methods and principles in medicinal chemistry
  9. Assessing the Stability of Molecular Glues with Weighted Ensemble Simulations
    Seref Berk Atik, Alex Dickson · 2026 · Journal of Chemical Theory and Computation
  10. Protease-mediated degradation
    Lu Yang, Haiting Duan, Xinfei Mao, Bizhi Li, Jinxin Che, Xiaowu Dong · 2025 · Elsevier eBooks
  11. Molecular Glues as Activators for PPI
    Xiangbing Qi · 2025
  12. Modular RNA-based PROTACs for selective degradation of multidomain RNA-binding proteins
    Florian Malard, Léa Bouton, Giulia Chiarazzo, Corinne Burre, Brune Vialet, Samuel Amintas, Sébastien Campagne · 2025 · Research Square
  13. Progress on molecular glue degraders
    Jiaqi Chen, Zhiheng Deng, Haoxiang Li, Lei Liu · 2025 · Scientia Sinica Chimica
  14. Abnormalities in Cell Cycle Control in Human Cancer and Their Relevance to Chemoprevention
    Alessandro Sgambato, I. Bernard Weinstein · 2004 · Humana Press eBooks
  15. Medicinal chemistry approaches to modulation of splicing, RNA modifications, and RNA editing in cancer therapeutics
    Hartmut Schirok, Lutz Lehmann, Hanna Torianyk, Nathalie Kary, Annita Louloupi, Razvan Nutiu, Yi‐Tao Yu, Pedro Morais · 2025 · Elsevier eBooks
  16. Assessing the Stability of Molecular Glues with Weighted Ensemble Simulations
    Seref Berk Atik, Alex Dickson · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Conception et synthèse d’inhibiteurs sélectifs de protéines kinases pour le traitement de l’allodynie mécanique
    Alexia Visseq · 2019
  18. Deconvoluting the multi-faceted roles of alternative splicing events in cancer: From underlying mechanisms to innovative therapeutics
    Lei Hu, Xiaofang Wang, Bo Fan, Qian Zhao, Yajun Zhong, Yingying Lu, Minru Liao, Hongyao Li, Xiangyu Fu, H Wang et al. · 2026 · Acta Pharmaceutica Sinica B
  19. Molecular Glue-Mediated Targeted Protein Degradation: Mechanisms and Therapeutic Potential in Prostate Cancer
    一榕 郑 · 2026 · Journal of Organic Chemistry Research
  20. BindingDB Entry 50037419: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
    BindingDB · 2012 · UC San Diego
  21. BindingDB Entry 50011291: Monomeric Targeted Protein Degraders.
    BindingDB · 2022 · UC San Diego
  22. BindingDB Entry 50038924: Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
    BindingDB · 2012 · UC San Diego
  23. BindingDB Entry 50042094: Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
    BindingDB · 2013 · UC San Diego
  24. BindingDB Entry 50035440: Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
    BindingDB · 2012 · UC San Diego
  25. BindingDB Entry 2958: Design, Structure-Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa Inhibitors.
    BindingDB · 2009 · UC San Diego
  26. BindingDB Entry 50010153: Arylsulfonyl-N,N-diethyl-dithiocarbamates: a novel class of antitumor agents.
    BindingDB · 2009 · UC San Diego
  27. BindingDB Entry 50035410: Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride.
    BindingDB · 2012 · UC San Diego
  28. BindingDB Entry 1692: Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates.
    BindingDB · 2007 · UC San Diego
  29. BindingDB Entry 50035377: Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX.
    BindingDB · 2012 · UC San Diego
  30. BindingDB Entry 50039202: Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases.
    BindingDB · 2012 · UC San Diego
  31. BindingDB Entry 50020994: Facilitating the development of molecular glues: Opportunities from serendipity and rational design.
    BindingDB · 2025 · UC San Diego
  32. BindingDB Entry 50016162: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    BindingDB · 2009 · UC San Diego
  33. BindingDB Entry 50032722: Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
    BindingDB · 2011 · UC San Diego
  34. BindingDB Entry 50047707: Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure.
    BindingDB · 2017 · UC San Diego
  35. BindingDB Entry 50020357: Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches.
    BindingDB · 2024 · UC San Diego
  36. BindingDB Entry 50037362: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    BindingDB · 2012 · UC San Diego
  37. BindingDB Entry 50037426: Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
    BindingDB · 2012 · UC San Diego
  38. BindingDB Entry 50033590: Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.
    BindingDB · 2012 · UC San Diego
  39. BindingDB Entry 50007174: Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity.
    BindingDB · 2021 · UC San Diego
  40. BindingDB Entry 50037370: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    BindingDB · 2012 · UC San Diego
  41. BindingDB Entry 50035442: Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    BindingDB · 2012 · UC San Diego
  42. Manipulating the Tumor Microenvironment for Therapeutic Benefit
    Kate M. Bailey · 2014 · Digital Commons - University of South Florida (University of South Florida)